Table 1.

Clinical characteristics of individuals from the BPS used in this study, for training predictive models

Variable	Total population	Non-progressors	Progressors	p value
n	543	397	146
Sex
Male	274	200	74	1
Female	269	197	72
Age (years)	49.33 ± 0.59	48.22 ± 0.72	52.34 ± 0.99	0.00089
BMI (kg/m2)	26.59 ± 0.18	25.91 ± 0.19	28.46 ± 0.37	4.5 × 10−9
Waist circumference (cm)	90.34 ± 0.54	88.19 ± 0.59	96.15 ± 1.04	2.2 × 10−10
Fasting glucose (mmol/l)	5.68 ± 0.03	5.60 ± 0.03	5.90 ± 0.05	8.0 × 10−7
Fasting insulin (pmol/l)	44.33 ± 1.61	38.85 ± 1.26	59.34 ± 4.71	4.4 × 10−5
SBP (mmHg)	132 ± 0.84	129.47 ± 0.95	138.87 ± 1.60	9.6 × 10−7
DBP (mmHg)	80.11 ± 0.47	78.70 ± 0.55	83.94 ± 0.86	5.2 × 10−7
Total cholesterol (mmol/l)	5.71 ± 0.05	5.68 ± 0.07	5.81 ± 0.09	0.21
HDL-cholesterol (mmol/l)	1.33 ± 0.01	1.35 ± 0.01	1.27 ± 0.03	0.02
Triacylglycerols (mmol/l)	1.44 ± 0.04	1.34 ± 0.04	1.69 ± 0.08	0.00014
Family history of type 2 diabetes
No	30	27	3	0.01
Yes	289	190	99
Data missing	224	180	44
Future CVD
No	419	305	114	1
Yes	124	92	32
Physical activity
Low	18	12	6	0.07
Medium	315	222	93
High	184	146	38
Data missing	26	17	9
Hypertension medication
No	275	214	61	1
Yes	60	41	19
Data missing	208	142	66

Data are n or means ± SEM.